Benjamin Edwards’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Other funds holding TXG
Benjamin Edwards's TXG Position: Q3 2026 in Review
Benjamin Edwards reduced its 10x Genomics (TXG) stake by 38% in Q3 2026, selling an estimated $1.15M and leaving 31,654 shares worth $2.86M. The position accounts for 0.03% of the portfolio, ranked #482.
Benjamin Edwards first reported a position in TXG in Q1 2021 and has held it in 23 quarters since. 377 funds tracked by Wall St. Rank hold TXG as of Q3 2026.
- Benjamin Edwards held 31,654 shares of 10x Genomics worth $2.86M as of Q3 2026.
- Benjamin Edwards sold 19,681 10x Genomics shares in Q3 2026, an estimated $1.15M.
- 10x Genomics made up 0.03% of Benjamin Edwards's portfolio in Q3 2026, its #482 holding.
- Benjamin Edwards first reported a position in 10x Genomics in Q1 2021 and has held it in 23 quarters since.
- 377 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.
Based on Benjamin Edwards's 13F filing for Q3 2026, filed 12 Nov 2026.